149 related articles for article (PubMed ID: 17680814)
41. Toxoplasma Encephalitis following Tandem Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Review of the Literature.
Kollu V; Magalhaes-Silverman M; Tricot G; Ince D
Case Rep Infect Dis; 2018; 2018():9409121. PubMed ID: 30534451
[TBL] [Abstract][Full Text] [Related]
42. Individualized intervention guided by BCR-ABL transcript levels after HLA-identical sibling donor transplantation improves HSCT outcomes for patients with chronic myeloid leukemia.
Huang XJ; Xu LP; Liu KY; Liu DH; Chen H; Liu YR; Chen YH; Han W; Wang Y
Biol Blood Marrow Transplant; 2011 May; 17(5):649-56. PubMed ID: 20691800
[TBL] [Abstract][Full Text] [Related]
43. Cutaneous toxoplasmosis after bone marrow transplantation with molecular confirmation.
Amir G; Salant H; Resnick IB; Karplus R
J Am Acad Dermatol; 2008 Nov; 59(5):781-4. PubMed ID: 18723241
[TBL] [Abstract][Full Text] [Related]
44. Allogeneic peripheral blood stem cell transplantation using reduced intensity versus myeloablative conditioning regimens for the treatment of leukemia.
Vela-Ojeda J; García-Ruiz Esparza MA; Tripp-Villanueva F; Ayala-Sánchez M; Delgado-Lamas JL; Garcés-Ruiz O; Rubio-Jurado B; Montiel-Cervantes L; Sánchez-Cortés E; García-Chavez J; Xolotl-Castillo M; Rosas-Cabral A; Salazar-Exaire D; Galindo-Rodríguez G; Aviña-Zubieta A
Stem Cells Dev; 2004 Oct; 13(5):571-9. PubMed ID: 15588514
[TBL] [Abstract][Full Text] [Related]
45. Systemic toxoplasmosis post allogeneic stem cell transplantation (Allo-SCT): lessons learned from HIV?
von Lilienfeld-Toal M; Gilleece M; Cook G
Biol Blood Marrow Transplant; 2007 Jul; 13(7):871-2. PubMed ID: 17580266
[No Abstract] [Full Text] [Related]
46. Acute encephalopathy in the immune-compromised child: never forget toxoplasmosis.
Caselli D; Andreoli E; Paolicchi O; Savelli S; Guidi S; Pecile P; Aricò M
J Pediatr Hematol Oncol; 2012 Jul; 34(5):383-6. PubMed ID: 22627571
[TBL] [Abstract][Full Text] [Related]
47. Real-time PCR for diagnosis and follow-up of Toxoplasma reactivation after allogeneic stem cell transplantation using fluorescence resonance energy transfer hybridization probes.
Costa JM; Pautas C; Ernault P; Foulet F; Cordonnier C; Bretagne S
J Clin Microbiol; 2000 Aug; 38(8):2929-32. PubMed ID: 10921953
[TBL] [Abstract][Full Text] [Related]
48. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
[TBL] [Abstract][Full Text] [Related]
49. T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantation.
Drobyski WR; Hessner MJ; Klein JP; Kabler-Babbitt C; Vesole DH; Margolis DA; Keever-Taylor CA
Blood; 1999 Jul; 94(2):434-41. PubMed ID: 10397710
[TBL] [Abstract][Full Text] [Related]
50. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
51. Is there a role for autologous stem cell transplantation for patients with acute myelogenous leukemia? A retrospective analysis.
Novitzky N; Thomas V; du Toit C; McDonald A
Biol Blood Marrow Transplant; 2011 Jun; 17(6):875-84. PubMed ID: 20870030
[TBL] [Abstract][Full Text] [Related]
52. Toxoplasmic Encephalitis with Untreated Hairy Cell Leukemia Variant.
Ikebe T; Sasaki H; Takata H; Miyazaki Y; Ohtsuka E; Saburi Y; Ogata M; Shirao K
Intern Med; 2016; 55(21):3175-3180. PubMed ID: 27803415
[TBL] [Abstract][Full Text] [Related]
53. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
[TBL] [Abstract][Full Text] [Related]
54. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
[TBL] [Abstract][Full Text] [Related]
55. Superiority of allogeneic hematopoietic stem cell transplantation to nilotinib and dasatinib for adult patients with chronic myelogenous leukemia in the accelerated phase.
Xu L; Zhu H; Hu J; Wu D; Jiang H; Jiang Q; Huang X
Front Med; 2015 Sep; 9(3):304-11. PubMed ID: 26100855
[TBL] [Abstract][Full Text] [Related]
56. Patients with Philadelphia-positive leukemia with BCR-ABL kinase mutations before allogeneic transplantation predominantly relapse with the same mutation.
Egan DN; Beppu L; Radich JP
Biol Blood Marrow Transplant; 2015 Jan; 21(1):184-9. PubMed ID: 25300870
[TBL] [Abstract][Full Text] [Related]
57. Transplantation of peripheral blood progenitor cells from HLA-identical sibling donors. European Group for Blood and Marrow Transplantation (EBMT).
Schmitz N; Bacigalupo A; Labopin M; Majolino I; Laporte JP; Brinch L; Cook G; Deliliers GL; Lange A; Rozman C; Garcia-Conde J; Finke J; Domingo-Albos A; Gratwohl A
Br J Haematol; 1996 Dec; 95(4):715-23. PubMed ID: 8982051
[TBL] [Abstract][Full Text] [Related]
58. Toxoplasmic encephalitis after allogeneic hematopoietic stem cell transplantation.
Cetinkaya FI; Mumcu N; Unuvar GK; Kilic AU; Kaynar L
North Clin Istanb; 2022; 9(3):282-285. PubMed ID: 36199860
[TBL] [Abstract][Full Text] [Related]
59. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
[TBL] [Abstract][Full Text] [Related]
60. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
